Acasti Pharma Inc (ACST)
2.69
-0.07
(-2.53%)
USD |
NASDAQ |
May 17, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Acasti Pharma Accounts Payable (Quarterly): 0.913M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.913M |
September 30, 2023 | 0.685M |
June 30, 2023 | 0.607M |
March 31, 2023 | 1.242M |
December 31, 2022 | 3.36M |
September 30, 2022 | 3.735M |
June 30, 2022 | 3.062M |
March 31, 2022 | 1.678M |
December 31, 2021 | 2.843M |
September 30, 2021 | 4.433M |
June 30, 2021 | 2.279M |
March 31, 2021 | 0.115M |
December 31, 2020 | 2.143M |
September 30, 2020 | 3.67M |
June 30, 2020 | 5.90M |
March 31, 2020 | 1.713M |
December 31, 2019 | 9.449M |
September 30, 2019 | 10.16M |
June 30, 2019 | 11.90M |
March 31, 2019 | 3.047M |
December 31, 2018 | 10.17M |
September 30, 2018 | 10.20M |
June 30, 2018 | 7.792M |
March 31, 2018 | 2.648M |
December 31, 2017 | 3.974M |
Date | Value |
---|---|
September 30, 2017 | 2.679M |
June 30, 2017 | 1.492M |
November 30, 2016 | 1.299M |
August 31, 2016 | 1.039M |
May 31, 2016 | 1.143M |
February 29, 2016 | 0.2767M |
November 30, 2015 | 1.191M |
August 31, 2015 | 0.8163M |
May 31, 2015 | 0.9645M |
February 28, 2015 | 0.197M |
November 30, 2014 | 1.095M |
August 31, 2014 | 1.301M |
May 31, 2014 | 1.552M |
February 28, 2014 | 0.2873M |
November 30, 2013 | 2.024M |
August 31, 2013 | 1.287M |
May 31, 2013 | 0.6189M |
February 28, 2013 | 0.3176M |
November 30, 2012 | 0.9018M |
August 31, 2012 | 0.832M |
May 31, 2012 | 0.80M |
February 29, 2012 | 0.5524M |
November 30, 2011 | 0.7067M |
August 31, 2011 | 0.9766M |
May 31, 2011 | 0.6469M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.115M
Minimum
Mar 2021
11.90M
Maximum
Jun 2019
3.678M
Average
2.843M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 4.327M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.0477M |
Xenon Pharmaceuticals Inc | 6.43M |
ESSA Pharma Inc | 2.041M |